These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33303714)

  • 1.
    Sun X; Zhang B; Xu G; Chen J; Shang Y; Lin Z; Yu Z; Zheng J; Bai B
    Ann Lab Med; 2021 May; 41(3):293-301. PubMed ID: 33303714
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Zeng W; Zhang X; Liu Y; Zhang Y; Xu M; Wang S; Sun Y; Zhou T; Chen L
    Front Microbiol; 2022; 13():1043736. PubMed ID: 36483205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative
    Mirza HC; Güçlü AÜ; İnce Ceviz G; Başustaoğlu A
    J Med Microbiol; 2022 Oct; 71(10):. PubMed ID: 36301611
    [No Abstract]   [Full Text] [Related]  

  • 4.
    Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
    Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antibacterial activities and resistance mechanisms of omadacycline and tigecycline against Enterococcus faecium.
    Liu X; Zhang C; Zhao Y; Cheng H; Wang Y; Wang Z; Shang Y; Zheng J; Yu Z; Shi Y
    J Antibiot (Tokyo); 2022 Aug; 75(8):463-471. PubMed ID: 35760902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AdeABC Efflux Pump Controlled by AdeRS Two Component System Conferring Resistance to Tigecycline, Omadacycline and Eravacycline in Clinical Carbapenem Resistant
    Lee YT; Chen HY; Yang YS; Chou YC; Chang TY; Hsu WJ; Lin IC; ; Sun JR
    Front Microbiol; 2020; 11():584789. PubMed ID: 33224122
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Kaushik A; Ammerman NC; Martins O; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).
    Tsai HY; Lee YL; Liu PY; Lu MC; Shao PL; Lu PL; Cheng SH; Ko WC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Lee WS; Shi ZY; Chen YS; Wang FD; Tseng SH; Chen YH; Sheng WH; Lee CM; Chen YH; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2021 Jul; 58(1):106353. PubMed ID: 33961991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Tet(L) Efflux Pump Variants Conferring Resistance to Tigecycline and Eravacycline in Staphylococcus Spp.
    Wang N; Li D; Schwarz S; Qin S; Yao H; Du XD
    Microbiol Spectr; 2021 Dec; 9(3):e0131021. PubMed ID: 34878306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity
    Li A; He S; Li J; Zhang Z; Li B; Chu H
    Microbiol Spectr; 2023 Jun; 11(3):e0071823. PubMed ID: 37140428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017-2020.
    Lee YL; Ko WC; Lee WS; Lu PL; Chen YH; Cheng SH; Lu MC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Shao PL; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Tang HJ; Hsueh PR
    Int J Antimicrob Agents; 2021 Sep; 58(3):106377. PubMed ID: 34166777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018-2020.
    Liu PY; Ko WC; Lee WS; Lu PL; Chen YH; Cheng SH; Lu MC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Shao PL; Lee YL; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Tang HJ; Hsueh PR
    J Microbiol Immunol Infect; 2022 Oct; 55(5):888-895. PubMed ID: 34521591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antimicrobial efficacy of eravacycline and tigecycline against clinical isolates of Streptococcus agalactiae in China: In vitro activity, heteroresistance, and cross-resistance.
    Li P; Wei Y; Li G; Cheng H; Xu Z; Yu Z; Deng Q; Shi Y
    Microb Pathog; 2020 Dec; 149():104502. PubMed ID: 32947016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of plasmid-borne
    Liu X; Liu Y; Ma X; Chen R; Li C; Fu H; Yang Y; Guo K; Zhang X; Liu R; Xu H; Zhu J; Zheng B
    Microbiol Spectr; 2024 Jul; ():e0049624. PubMed ID: 39041815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017.
    Huband MD; Pfaller MA; Shortridge D; Flamm RK
    J Glob Antimicrob Resist; 2019 Dec; 19():56-63. PubMed ID: 30825698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of
    Zhou Q; Xu W; Zhu X; Zhang J; Zhang Y; Han Y; Chen K; Yin Y
    Infect Drug Resist; 2022; 15():1383-1389. PubMed ID: 35386292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of new tetracycline analogues omadacycline and eravacycline against clinical isolates of Helicobacter pylori collected in China.
    Yang Y; Bian L; Hang X; Yan C; Huang Y; Ye F; Zhang G; Jin G; Bi H
    Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115129. PubMed ID: 32739761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of omadacycline in vitro against bacteria isolated from 2014 to 2017 in China, a multi-center study.
    Xiao M; Huang JJ; Zhang G; Yang WH; Kong F; Kudinha T; Xu YC
    BMC Microbiol; 2020 Nov; 20(1):350. PubMed ID: 33198626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018.
    Pfaller MA; Huband MD; Shortridge D; Flamm RK
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of common Enterobacterales to eravacycline in Taiwan.
    Huang CF; Wang JT; Chuang YC; Sheng WH; Chen YC
    J Microbiol Immunol Infect; 2023 Apr; 56(2):358-366. PubMed ID: 36243669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.